Where policy, physician alignment, and commercial strategy converge.

Payment reform, regulatory change, and physician relationships each shape the commercial outcome of a cleared device in ways that most commercial teams underestimate. This is the terrain the firm works in. Analysis published here addresses those forces directly, from how episode-based payment changes the relationship between device companies and the physicians who use their products, to how prior authorization policy affects the physician's decision to adopt.

To discuss a specific commercial challenge, contact the firm directly.